New molecular medicine-based scar management strategies.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Burns

• Publication date

  2014-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.burns.2013.11.010PMID 24438742PMCID PMC4008699
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Early growth response 3 (Egr-3) is induced by transforming growth factor-β and regulates fibrogenic responses.

  2013cited by this paper
• Differential topical susceptibility to TGFβ in intact and injured regions of the epithelium: key role in myofibroblast transition

  2013cited by this paper
• Thymosin β4: a multi-functional regenerative peptide. Basic properties and clinical applications

  2012cited by this paper
• TGFβ3 IMMUNOASSAY STANDARDIZATION: COMPARISON OF NIBSC REFERENCE PREPARATION CODE 98/608 WITH AVOTERMIN LOT 205-0505-005

  2012cited by this paper
• Thymosin Beta 4 Is Dispensable for Murine Cardiac Development and Function

  2012cited by this paper
• Effect of tetrandrine on the TGF-β-induced smad signal transduction pathway in human hypertrophic scar fibroblasts in vitro.

  2012cited by this paper
• [Effect of different concentration of tamoxifen ointment on the expression of TGF-beta2 of hypertrophic scar at rabbit ears].

  2011cited by this paper
• Asiaticoside suppresses collagen expression and TGF-β/Smad signaling through inducing Smad7 and inhibiting TGF-βRI and TGF-βRII in keloid fibroblasts

  2011cited by this paper
• Effects of Hepatocyte Growth Factor on Collagen Synthesis and Matrix Metalloproteinase Production in Keloids

  2011cited by this paper
• Small leucine‐rich proteoglycans, decorin and fibromodulin, are reduced in postburn hypertrophic scar

  2011cited by this paper
• Matrix remodeling stimulates stromal autophagy, “fueling” cancer cell mitochondrial metabolism and metastasis

  2011cited by this paper
• Exploring anti-TGF-β therapies in cancer and fibrosis

  2011cited by this paper
• Differential collagen-glycosaminoglycan matrix remodeling by superficial and deep dermal fibroblasts: potential therapeutic targets for hypertrophic scar.

  2011cited by this paper
• Deconstructing fibrosis research: do pro-fibrotic signals point the way for chronic dermal wound regeneration?

  2011cited by this paper
• Endoglin promotes TGF‐β/Smad1 signaling in scleroderma fibroblasts

  2011cited by this paper
• Vitamin D: a novel therapeutic approach for keloid, an in vitro analysis

  2011cited by this paper
• Sirolimus drug-eluting, hydrogel-impregnated polypropylene mesh reduces intra-abdominal adhesion formation in a mouse model.

  2011cited by this paper
• Role of caveolin‐1 in the pathogenesis of tissue fibrosis by keloid‐derived fibroblasts in vitro

  2011cited by this paper
• Intradermal tacrolimus prevent scar hypertrophy in a rabbit ear model: a clinical, histological and spectroscopical analysis

  2011cited by this paper
• Hypertrophic Scarring and Keloids: Pathomechanisms and Current and Emerging Treatment Strategies

  2011influential reference
• Endoglin in liver fibrosis

  2011cited by this paper
• Collagen-Binding Peptidoglycans Inhibit MMP Mediated Collagen Degradation and Reduce Dermal Scarring

  2011cited by this paper
• c-Ski in health and disease

  2011cited by this paper
• The effect of Mannose-6-Phosphate on recovery after sciatic nerve repair.

  2011influential reference
• Phase II AIDS Malignancy Consortium Trial of Topical Halofuginone in AIDS-Related Kaposi Sarcoma

  2011cited by this paper
• Fussel-15, a new player in wound healing, is deregulated in keloid and localized scleroderma.

  2011cited by this paper
• Current immunosuppressive treatment after kidney transplantation

  2011cited by this paper
• Transforming Growth Factor-β and Endoglin Signaling Orchestrate Wound Healing

  2011cited by this paper
• Ski, a modulator of wound healing and scar formation in the rat skin and rabbit ear

  2011influential reference
• Internalization and intracellular trafficking of a PTD-conjugated anti-fibrotic peptide, AZX100, in human dermal keloid fibroblasts.

  2010cited by this paper
• Animal studies with thymosin β4, a multifunctional tissue repair and regeneration peptide

  2010cited by this paper
• Evaluating Tamoxifen Effect in the Prevention of Hypertrophic Scars Following Surgical Incisions

  2010cited by this paper
• Treatment with rapamycin prevents fibrosis in tight-skin and bleomycin-induced mouse models of systemic sclerosis.

  2010cited by this paper
• Effect of the Inhibitor Peptide of the Transforming Growth Factor β (p144®) in a New Silicone Pericapsular Fibrotic Model in Pigs

  2010cited by this paper
• Increased expression of fibroblast activation protein-alpha in keloid fibroblasts: implications for development of a novel treatment option

  2010cited by this paper
• Differential expression of procollagen genes between mid- and late-gestational fetal fibroblasts.

  2009cited by this paper
• Cell permeant peptide analogues of the small heat shock protein, HSP20, reduce TGF-beta1-induced CTGF expression in keloid fibroblasts.

  2009cited by this paper
• Differential expression of cyclooxygenases in hypertrophic scar and keloid tissues

  2009cited by this paper
• Nucleocytoplasmic shuttling of Smad proteins

  2009cited by this paper
• Evidence Based Review for the Treatment of Post-burn Pruritus

  2009cited by this paper
• Transforming Growth Factor-&bgr; and Angiotensin in Fibrosis and Burn Injuries

  2009cited by this paper
• Hypertrophic Scars and Keloids—A Review of Their Pathophysiology, Risk Factors, and Therapeutic Management

  2009influential reference
• The expression of SnoN in normal human skin and cutaneous keratinous neoplasms

  2009cited by this paper
• Non-Smad pathways in TGF-β signaling

  2009influential reference
• Differential regulation of human thymosin beta 15 isoforms by transforming growth factor beta 1

  2009cited by this paper
• Low decorin expression along with inherent activation of ERK1,2 in ear lobe keloids.

  2009cited by this paper
• TGF-beta and fibrosis in different organs - molecular pathway imprints.

  2009cited by this paper
• Regulating the stability of TGFβ receptors and Smads

  2009influential reference
• Topical tamoxifen therapy in hypertrophic scars or keloids in burns

  2009cited by this paper
• Recombinant human decorin inhibits TGF-beta1-induced contraction of collagen lattice by hypertrophic scar fibroblasts.

  2009cited by this paper
• Prophylactic administration of avotermin for improvement of skin scarring: three double-blind, placebo-controlled, phase I/II studies.

  2009cited by this paper
• Endocytic regulation of TGF-β signaling

  2009cited by this paper
• Ski and SnoN, potent negative regulators of TGF-β signaling

  2009influential reference
• c-Ski, Smurf2, and Arkadia as regulators of TGF-beta signaling: new targets for managing myofibroblast function and cardiac fibrosis.

  2009cited by this paper
• Roles of TGF-β family signaling in stem cell renewal and differentiation

  2009cited by this paper
• Management of keloids and hypertrophic scars.

  2009cited by this paper
• Roles of TGFβ in metastasis

  2009cited by this paper
• The emerging role of TGF-beta superfamily coreceptors in cancer.

  2009cited by this paper
• Regulation of TGF-β signaling by Smad7

  2009cited by this paper
• Dietary flavonoids as antioxidants.

  2009cited by this paper
• Phospho-control of TGF-β superfamily signaling

  2009cited by this paper
• TGF-β-induced epithelial to mesenchymal transition

  2009cited by this paper
• Signaling cross-talk between TGF-β/BMP and other pathways

  2009cited by this paper
• Novel therapies for scar reduction and regenerative healing of skin wounds.

  2008cited by this paper
• The role of proteases in transforming growth factor-beta activation.

  2008cited by this paper
• [The expression of fibrillin 1 in pathologic scars and its significance].

  2008cited by this paper
• New therapeutics for the prevention and reduction of scarring.

  2008cited by this paper
• Efficacy of Rapamycin in Scleroderma: A Case Study

  2008cited by this paper
• Avotermin: A Novel Antiscarring Agent

  2008cited by this paper
• Effects of asiaticoside on the expression of Smad protein by normal skin fibroblasts and hypertrophic scar fibroblasts

  2008cited by this paper
• Cellular and molecular mechanisms of fibrosis

  2008cited by this paper
• Evaluating the tolerability and efficacy of etanercept compared to triamcinolone acetonide for the intralesional treatment of keloids.

  2008cited by this paper
• Inhibitors of dipeptidyl peptidase IV-like activity mediate antifibrotic effects in normal and keloid-derived skin fibroblasts.

  2008cited by this paper
• Design of a synthetic collagen-binding peptidoglycan that modulates collagen fibrillogenesis.

  2008cited by this paper
• Targeting the TGFbeta, endothelin-1 and CCN2 axis to combat fibrosis in scleroderma.

  2008cited by this paper
• The role of Smads in skin development.

  2008cited by this paper
• Trichostatin A prevents the accumulation of extracellular matrix in a mouse model of bleomycin-induced skin fibrosis.

  2007cited by this paper
• TNF-α Suppresses α-Smooth Muscle Actin Expression in Human Dermal Fibroblasts: An Implication for Abnormal Wound Healing

  2007cited by this paper
• Cutaneous Wound Healing

  2007cited by this paper
• Mannose 6-phosphate receptor targeting and its applications in human diseases.

  2007influential reference
• A role for TGF-beta1-induced cellular responses during wound healing of the non-scarring early human fetus?

  2007influential reference
• Fussel-15, a novel Ski/Sno homolog protein, antagonizes BMP signaling.

  2007cited by this paper
• mTOR as a potential therapeutic target for treatment of keloids and excessive scars

  2007cited by this paper
• Multiple Transforming Growth Factor-β Isoforms and Receptors Function during Epithelial-Mesenchymal Cell Transformation in the Embryonic Heart

  2007cited by this paper
• Thymosin beta 4 suppression of corneal NFkappaB: a potential anti-inflammatory pathway.

  2007cited by this paper
• Keloids: pathophysiology and management.

  2007cited by this paper
• Inhibition of Smad3 expression decreases collagen synthesis in keloid disease fibroblasts.

  2007cited by this paper
• TGF-beta signaling in vascular fibrosis.

  2007cited by this paper
• TNF-alpha suppresses alpha-smooth muscle actin expression in human dermal fibroblasts: an implication for abnormal wound healing.

  2007cited by this paper
• TGF-β signaling in vascular fibrosis

  2007cited by this paper
• TGFbeta pathobiology in the eye.

  2006cited by this paper
• Y-box protein-1 is the crucial mediator of antifibrotic interferon-gamma effects.

  2006cited by this paper
• Thymosin β4 promotes matrix metalloproteinase expression during wound repair

  2006cited by this paper
• TGFβ pathobiology in the eye

  2006cited by this paper
• Antifibrotic effects of hepatocyte growth factor on scleroderma fibroblasts and analysis of its mechanism

  2006cited by this paper
• Treatment of Keloids and Hypertrophic Scars

  2006cited by this paper
• Y-box Protein-1 Is the Crucial Mediator of Antifibrotic Interferon-γ Effects*

  2006cited by this paper
• hepatocyte growth factor is a downstream effector that mediates the antifibrotic action of peroxisome proliferator-activated receptor-gamma agonists.

  2006cited by this paper
• [Cellular and molecular mechanisms of fibrosis].

  2006cited by this paper
• Ubiquitin-dependent degradation of SnoN and Ski is increased in renal fibrosis induced by obstructive injury.

  2006cited by this paper

• Pathogenesis of Fibrosis in Patella-Patellar Tendon Junction Induced by Jumping Load in a Rabbit Model.

  2025cites this paper
• Research Trends and Hotspots in Hypertrophic Scar: A Bibliometric Analysis over the Past Five Decades

  2025cites this paper
• The role of NLRP3-PGE2 axis in mediating interactions between bovine endometrial myofibroblasts and M1 macrophages.

  2025cites this paper
• Cadherin-11 targeted cell-specific liposomes enabled skin fibrosis treatment by inducing apoptosis.

  2024cites this paper
• The Promoting Effect of Animal Bioactive Proteins and Peptide Components on Wound Healing: A Review

  2024cites this paper
• Using network pharmacology to discover potential drugs for hypertrophic scars.

  2024cites this paper
• Adipose‐derived stem cells enriched with therapeutic mRNA TGF‐β3 and IL‐10 synergistically promote scar‐less wound healing in preclinical models

  2023cites this paper
• Remarkable efficiency of surgical shave excision of keloids followed by intralesional injection of Bleomycin. A retrospective study of 314 cases

  2022cites this paper
• Comparative Efficacy of Intralesional Triamcinolone Acetonide and 5-Fluorouracil for Keloid Scars

  2022cites this paper
• The Emerging Therapeutic Targets for Scar Management: Genetic and Epigenetic Landscapes

  2022cites this paper
• The Ubiquitin Proteasome System and Skin Fibrosis

  2021cites this paper
• Collagen Peptides Derived from Sipunculus nudus Accelerate Wound Healing

  2021cites this paper
• Botulinum Toxin Type A and Its Possible Mechanisms on Wound Healing

  2020cites this paper
• Objective evaluation of an occlusive overnight intensive patch (OIP) containing onion extract and allantoin for hypertrophic scars.

  2020cites this paper
• Pathogenesis and Development of Patellar Tendon Fibrosis in a Rabbit Overuse Model

  2020cites this paper
• Clinical Insights into the Importance of Scars and Scar Release in Paediatric Chronic Myofascial Pain

  2020cites this paper
• [Wound-healing acceleration of mice skin by Sipunculus nudus extract and its mechanism].

  2020cites this paper
• SnoN residue (1–366) attenuates hypertrophic scars through resistance to transforming growth factor-β1-induced degradation

  2019cites this paper
• Current and upcoming therapies to modulate skin scarring and fibrosis.

  2019cites this paper
• Novel pharmacotherapy for burn wounds: what are the advancements

  2018cites this paper
• In vitro effects of sEng and TGF‐β on human umbilical vein endothelial cells and trophoblasts

  2018influential citation
• Suppressive effect of bacoside A on hypertrophic scar formation by downregulation of TGF-β1

  2018cites this paper
• Efficacy of lentivirus‑mediated Drosophila melanogaster deoxyribonucleoside kinase combined with (E)‑5‑(2‑bromovinyl)‑2'‑deoxyuridine or 1‑β‑D‑arabinofuranosylthymine therapy in human keloid fibroblasts.

  2018cites this paper
• Lasers and ancillary treatments for scar management Part 2: Keloid, hypertrophic, pigmented and acne scars

  2017cites this paper
• Multiple growth factor delivery for skin tissue engineering applications

  2017cites this paper
• Serum albumin as a local therapeutic agent in cell therapy and tissue engineering

  2017cites this paper
• Structural Basis for the Interaction of a Human Small Heat Shock Protein with the 14-3-3 Universal Signaling Regulator.

  2017cites this paper
• Natural healing-inspired collagen-targeting surgical protein glue for accelerated scarless skin regeneration.

  2017cites this paper
• Coordinate activities of BRD4 and CDK9 in the transcriptional elongation complex are required for TGFβ-induced Nox4 expression and myofibroblast transdifferentiation

  2017cites this paper
• Le Scar Club devient la Global Scar Society

  2017cites this paper
• Using Amniotic Membrane as a Novel Method to Reduce Post-burn Hypertrophic Scar Formation: A Prospective Follow-up Study

  2017cites this paper
• Lower energy radial shock wave therapy improves characteristics of hypertrophic scar in a rabbit ear model

  2017cites this paper
• Evaluating the Therapeutic Success of Keloids Treated With Cryotherapy and Intralesional Corticosteroids Using Noninvasive Objective Measures

  2017cites this paper
• Regulation of collagen expression using nanoparticle mediated inhibition of TGF-β activation

  2016cites this paper
• Advances in Biopharmaceutical Agents and Growth Factors for Wound Healing and Scarring

  2016cites this paper
• Silencing NLRC5 inhibits extracellular matrix expression in keloid fibroblasts via inhibition of transforming growth factor-β1/Smad signaling pathway.

  2016cites this paper
• Outcomes of Cutaneous Scar Revision During Surgical Implant Removal in Children with Cerebral Palsy.

  2016cites this paper
• Baicalein attenuates hypertrophic scar formation via inhibition of the transforming growth factor‐β/Smad2/3 signalling pathway

  2016cites this paper
• Transforming growth factor beta (TGF‐β) isoforms in wound healing and fibrosis

  2016cites this paper
• PLGA based drug delivery systems: Promising carriers for wound healing activity

  2016cites this paper
• Rare genetic diseases, signalling pathways, and keloid scar formation

  2014cites this paper
• Crosstalk between umbilical cord wharton’s jellyderived- mesenchymal stem cells and human skin fibroblasts: implications in wound healing, fibrosis, anti-aging and burns.

  2014cites this paper
• On the horizon: research priorities in burns for the next decade.

  2014cites this paper
• Up-to-date approach to manage keloids and hypertrophic scars: a useful guide.

  2014cites this paper
• Internet‐based survey on current practice for evaluation, prevention, and treatment of scars, hypertrophic scars, and keloids

  2014cites this paper
• Transforming growth factor β3 attenuates the development of radiation-induced pulmonary fibrosis in mice by decreasing fibrocyte recruitment and regulating IFN-γ/IL-4 balance.

  2014cites this paper